Focus Partners Wealth’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Focus Partners Wealth's AZN Position: Q3 2026 in Review
Focus Partners Wealth reduced its AstraZeneca (AZN) stake by 8.3% in Q3 2026, selling an estimated $1.12M and leaving 74,545 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #656.
Focus Partners Wealth first reported a position in AZN in Q4 2023 and has held it in 12 quarters since. The position peaked at $15.4M in Q2 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Focus Partners Wealth held 74,545 shares of AstraZeneca worth $12M as of Q3 2026.
- Focus Partners Wealth sold 6,720 AstraZeneca shares in Q3 2026, an estimated $1.12M.
- AstraZeneca made up 0.01% of Focus Partners Wealth's portfolio in Q3 2026, its #656 holding.
- Focus Partners Wealth first reported a position in AstraZeneca in Q4 2023 and has held it in 12 quarters since.
- Focus Partners Wealth's AstraZeneca position peaked at $15.4M in Q2 2026.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.